Clinical Trial Update: Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating dendritic cell immunotherapy for pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Neoplasms

Snippet

Sponsor: The Republican Research and Practical Center for Epidemiology and Microbiology | Conditions: Dendritic Cells, Pancreatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED